Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)
Clinical trial NCT01357655 · TERMINATED
Trial details
- NCT number
- NCT01357655
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2016-01-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.